Developer docs
API playgroundTry for free, no card

Search company profiles

Respinova

Full company profile

uuid00037w8

Namestring
Respinova
Websiteurl
respinova.com
Company typeenum
Private
Founded yearint
2008
Short descriptiontext

Respinova is an Israel-based, privately-held medtech company founded in 2008 that develops treatments for COPD and other respiratory diseases. Operating with 1-10 employees, it has historically been funded by EU grants (EIC and EISMEA) and is currently pre-commercial with no active public-facing presence.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHerzliya, Israel
HQ citystring
Herzliya
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
COPD treatments, respiratory disease therapy, pulmonary medical devices, respiratory care technology, lung disease therapeutics
Industry2 codes
PRIMARYHLAKANAE
COPD & Chronic Bronchitis Management
SECONDARYHLAKANAL
Pulmonary Rehabilitation Programs
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Respiratory Medical Devices
Social media profiles1 record
Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Respinova develops treatments for Chronic Obstructive Pulmonary Disease (COPD) and other respiratory diseases. The company focuses on therapeutic solutions targeting pulmonary conditions, operating as a small private medical technology firm based in Herzliya, Israel. Its work centers on novel respiratory interventions for patients suffering from chronic airway and lung diseases.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1COPD Respiratory Treatment
CategoryRespiratory Therapeutics
Description

A treatment developed by Respinova targeting Chronic Obstructive Pulmonary Disease, intended for use by patients with chronic airway obstruction and related respiratory conditions.

No data
Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Respinova

Respiratory Medical Devicesrespinova.com

Respinova is an Israel-based, privately-held medtech company founded in 2008 that develops treatments for COPD and other respiratory diseases. Operating with 1-10 employees, it has historically been funded by EU grants (EIC and EISMEA) and is currently pre-commercial with no active public-facing presence.

Respinova firmographics

Firmographics
Name
Respinova
Website
https://respinova.com
Company type
Private
Founded year
2008
Headcount range
1–10 employees
Short description
Respinova is an Israel-based, privately-held medtech company founded in 2008 that develops treatments for COPD and other respiratory diseases. Operating with 1-10 employees, it has historically been funded by EU grants (EIC and EISMEA) and is currently pre-commercial with no active public-facing presence.
Ownership category
akta.pro rank

Respinova industry classification

Industry
Product category
Respiratory Medical Devices
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAKANAE
COPD & Chronic Bronchitis Management
SECONDARYHLAKANAL
Pulmonary Rehabilitation Programs

Keywords

  • COPD treatments
  • Respiratory disease therapy
  • Pulmonary medical devices
  • Respiratory care technology
  • Lung disease therapeutics

Where Respinova is headquartered

Location

Headquarters

HQ city
Herzliya
HQ country
Israel
HQ region
Middle East

Markets served

Respinova business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Respinova product offering

Product offering

Core offering

Respinova develops treatments for Chronic Obstructive Pulmonary Disease (COPD) and other respiratory diseases. The company focuses on therapeutic solutions targeting pulmonary conditions, operating as a small private medical technology firm based in Herzliya, Israel. Its work centers on novel respiratory interventions for patients suffering from chronic airway and lung diseases.

Differentiator

Problem solved

Functional benefit

Products and services

  • COPD Respiratory Treatment A treatment developed by Respinova targeting Chronic Obstructive Pulmonary Disease, intended for use by patients with chronic airway obstruction and related respiratory conditions.

Companies that use Respinova

Customer profile

Ideal customer profiles1 record

Respinova technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Respinova competitors and assessment

Company assessment

Market position

Customer concentration

Respinova social profiles

Digital presence

Respinova financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Respinova leadership team

Management profile

Number of profiles

Profiles4 records

Respinova funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Respinova M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Respinova

What does Respinova do?

Respinova develops treatments for Chronic Obstructive Pulmonary Disease (COPD) and other respiratory diseases. The company focuses on therapeutic solutions targeting pulmonary conditions, operating as a small private medical technology firm based in Herzliya, Israel. Its work centers on novel respiratory interventions for patients suffering from chronic airway and lung diseases.

When was Respinova founded?

Respinova was founded in 2008. It employs 1 to 10 people.

Where is Respinova based?

Respinova is headquartered in Herzliya, Israel, in the Middle East region.

Does Respinova have an API?

No public API is recorded for Respinova.

What industry is Respinova in?

Respinova's product category is Respiratory Medical Devices. Its primary akta.pro industry code is HLAKANAE, COPD & Chronic Bronchitis Management, with a secondary code of HLAKANAL, Pulmonary Rehabilitation Programs. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals